Interview with Rajiv Chopra, President DSM India & MD DSM Nutirtional…
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
Address: Windsor House, 401, Fourth Floor, | CST Road, Kalina | Mumbai 400098, India
Tel: + 91 22 4034 9100 / 101
Web: http://www.dsm.com/en_US/cworld/public/home/pages/home.jsp
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting
its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global markets such as food and
dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical
and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver
annual net sales of around € 9 billion. The company is listed on NYSE Euronext. More information can be
found at www.dsm.com.
DSM Nutritional Products is the world’s leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetic industries.
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage…
You have already publicly announced that, despite being late in India, Lonza has been increasingly looking into expanding in the Indian market. First of all, what do you think sparked…
Before moving into the company’s strategy, can you give our readers an idea of what role Boehringer Ingelheim India plays within the Group’s worldwide operations? Within the Boehringer Ingelheim Group,…
To start off, can you tell us how you have seen the pharmaceutical industry developing in India? Has the perception of India by big pharma changed over the years? First…
A catalyst of India’s shifting industry dynamics has been the sector’s M&A activity. We already saw majors such as Piramal going to Abbott and Ranbaxy to Daiichi-Sankyo… And while Andrew…
With the recent event “Vibrant Gujarat”, the state of Gujarat aimed to showcase the region’s opportunities and advanced infrastructure, hosting 1,400 delegates from 101 countries as well as several presentations…
You founded Calyx in 1979 with a three-person team. At the time, you were just 21 years old! What was the vision behind the creation of the company? Essentially, the…
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it…
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been…
See our Cookie Privacy Policy Here
